Dr Reddy's Laboratories CEO: 'very positive outlook' for Indian pharma industry despite Trump 2.0
CEO of Dr Reddy's Laboratories, Erez Israeli believes his company's affordable medicines benefit the U.S. market and will be ...
Dr. Reddy's Laboratories underperforms Friday when compared to competitors
Dr. Reddy's Laboratories Ltd. 500124 shares slid 5.01% to 1,224.70 Indian rupees Friday, on what proved to be an all-around ...
Indian drugmaker Dr Reddy's shares slide after Q3 profit miss
Shares of Dr Reddy's Laboratories dropped 6% in early trade on Friday, a day after the company reported a third-quarter ...
Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ...
Dr Reddy's Laboratories Ltd (RDY) reports a robust 16% YoY revenue growth, driven by strategic product launches and market ...
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business
Dr. Reddy's Laboratories Ltd (NYSE:RDY) stock is trading lower after the company released third-quarter 2025 earnings. The pharma company clocked a net income of $165 million, marginally up from $161 ...
Dr Reddy's Labs shares slide 6% post Q3 results. Should you buy, sell, or hold?
Dr. Reddy's Laboratories shares fell by 6.2% after the company reported a marginal 2% YoY growth in Q3 FY25 net profit to Rs ...
devdiscourse23h
Dr Reddy's Laboratories Shares Plummet Despite Profit Increase
Shares of Dr Reddy's Laboratories fell by 5% as the company's third-quarter profit rise failed to impress investors. The ...
ndtvprofit1d
Dr. Reddy's Laboratories Q3 Results: Profit Rises 2%, But Misses Estimates
Dr. Reddy's Laboratories Ltd.'s profit rose 2% in the third quarter of the current financial year, but missed analysts' ...
devdiscourse1d
Dr Reddy's Laboratories Reports Modest Profit Rise Amid Revenue Surge
Dr Reddy's Laboratories reported a 2% increase in net profit to Rs 1,413 crore for the third quarter ending December 2024.
cnbctv181d
Dr Reddy's Laboratories Q3 Results | Net profit up 3%, revenue grows 16%; numbers lower than expected
Pharmaceutical major Dr Reddy's Laboratories Ltd on Thursday (January 23) reported a 2.5% year-on-year (YoY) increase in net ...
Reduce Dr. Reddy's Laboratories; target of Rs 1335: Prabhudas Lilladher
Prabhudas Lilladher recommended reduce rating on Dr. Reddy's Laboratories with a target price of Rs 1335 in its research ...
Dr. Reddy's Laboratories underperforms Thursday when compared to competitors
Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.54% to 1,289.35 Indian rupees Thursday, on what proved to be an all ...